Andrey Sorokin

6PUBLICATIONS
5CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Predictive and prognostic markersPreventative health careAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 02, 2025
Prevention of hypertension-induced renal vascular dysfunction through a p66Shc-targeted mechanism.

Bradley Miller, John D Imig, Mengjie Li

|Oct 29, 2021
Modulation of p66Shc impairs cerebrovascular myogenic tone in low renin but not low nitric oxide models of systemic hypertension.

William E Hughes, Joe Hockenberry, Bradley Miller

|Jun 17, 2019
The p52 isoform of SHC1 is a key driver of breast cancer initiation.

Kevin D Wright, Bradley S Miller, Sarah El-Meanawy

|Aug 23, 2018
Inactivation of p66Shc Decreases Afferent Arteriolar KATP Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats.

Bradley S Miller, Shoshana R Blumenthal, Alexey Shalygin

|Oct 06, 2017
Role of adaptor protein p66Shc in renal pathologies.

Kevin D Wright, Alexander Staruschenko, Andrey Sorokin

|Sep 24, 2017
Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.

Anna Alexanian, Andrey Sorokin

Pageof 1

Frequent Collaborators

2 joint publications

Alexander Staruschenko

2 joint publications

Bradley Miller

1 joint publications

William E Hughes

1 joint publications

Andreas M Beyer